IMAX Just Reported Its Best Summer Ever. The $55.60 Ceiling Now Decides the Next Move

IMAX Corporation (NYSE: IMAX) told the market Tuesday it just booked the most profitable summer in its history — $728 million in worldwide box office over the season, up 73% from the previous record, on just over 1,800 screens. That is a stunning number for a company that was written off during the pandemic as a premium-format luxury nobody needed anymore.

Here is the wrinkle the headline misses. The stock gapped up on the news this morning, opened near $52.50, and then faded back below the prior close to roughly $51.60 in early trading. The record is real. The question the chart is asking right now is whether the good news is already priced in near the highs — or whether this is the shallow dip that ends in a breakout.

The number is not a fluke. It is a mechanism.

The $728 million figure matters less as a record than as proof of how IMAX now makes money. IMAX does not own most of the theaters it plays in. It licenses its projection systems and takes a cut of the tickets sold on them, so its revenue is box-office grosses flowing through a network it does not have to build or staff at scale. Revenue in the second quarter was $103 million, up 12% year over year, on a record $285 million in Q2 box office.

The "just over 1,800 screens" detail is the whole business model in one line. IMAX took a record 5.8% of the entire summer's global box office from a fraction of the screens the big chains run — roughly 1,800 versus tens of thousands for the industry. It sells a premium seat, at a premium price, to a share of moviegoers that keeps growing even when attendance is flat. Premium large formats took 11.9% of the summer's domestic haul, up from 6.6% in 2019.

One film did most of the work — and that is the risk.

The engine was Christopher Nolan's The Odyssey, the first feature ever shot entirely with IMAX film cameras. It became IMAX's highest-grossing release of all time, pulling in roughly $486 million through IMAX screens alone — about 30% of the film's $1.6 billion global gross. IMAX contributed that much of a single film because whole audiences chose the big screen specifically for it.

Management is betting the effect is sticky. IMAX booked a record $1.28 billion in global box office in 2025 and has guided 2026 to another record near $1.4 billion, with a second half loaded with Dune: Part Three and Avengers: Doomsday to carry the baton from The Odyssey and Spider-Man: Brand New Day. But the concentration is blunt: more than a third of the entire summer's domestic gross came from just two films. If next year's slate misfires, the same leverage that multiplied this record can reverse it.

The chart: extended, near the highs, testing one ceiling

Set the fundamentals aside and look at the tape. IMAX is up about 40% this year, and over the last 120 trading days it has climbed roughly 32%. It sits well above both its 50-day average near $46.40 and its 200-day near $39.75 — in other words, the stock has been in a strong, persistent uptrend, and it is not cheap or oversold by any timing measure. Its 20-day volatility runs about 3.5%, so a single-day move of a few percent is normal motion here, not a scream.

The level that organizes everything is the 52-week high at $55.57, a line the stock touched but has not yet cleared on a close. Everything now runs through that ceiling:

Scenario	Trigger	Path	Invalidation	Horizon
Breakout	Close above ~$55.60 on rising volume	Empty air pocket to the upside, next decision zone into the high $50s / low $60s	Falls back under $53 within a session or two	Days to weeks
Rejection	Fails at $55.60, loses $51.60 today	Retest of the $50 shelf, then the 50-day near $46.40	Close back below $48–$50	This session onward

The fading open matters within this map. When a stock pushes up on a headline and gives the gain back to the prior close, those who bought the morning pop are suddenly underwater — trapped inventory that can supply selling if the ceiling holds. Do not read that as the end of the story; IMAX has defended its breakout shelf near $50 repeatedly during the run, and that is the line separating patient holders from the chase-buyers who bought too high today.

The verdict

Hold ~$55.60 and the record-summer story gets a fresh leg with the fall slate as fuel; lose $50 and this setups boils down to a buy-the-news head fake inside a longer uptrend, with the 50-day as the real support. The record confirms IMAX's economics are re-rating — it takes a growing premium share of a rebounding box office from a network it does not have to own. That is an investment thesis. But the trade right now is a test of one ceiling on live volume, and the ceiling, not the headline, is what decides the next move.

As of 08:58 ET, Sept. 8, 2026. Figure references are reported or estimated figures as labeled; the stock move is intraday and subject to change.